Literature DB >> 8931938

Hybrid oligonucleotides: synthesis, biophysical properties, stability studies, and biological activity.

D Yu1, R P Iyer, D R Shaw, J Lisziewicz, Y Li, Z Jiang, A Roskey, S Agrawal.   

Abstract

We have designed and synthesized hybrid oligonucleotides 2-5, as analogues of oligodeoxynucleoside phosphorothioates, in an effort to have agents with improved 'antisense activity' with reduced phosphorothioate content. The hybrid oligonucleotides contain segments of 2'-O-methyl ribonucleoside phosphoric diesters and oligodeoxynucleoside phosphorothioates. Thus, compared with the 'all' phosphorothioate analogues 1 and 6, the analogues 2-5 showed significantly reduced effect on complement activation. In addition, thermal denaturation studies with complementary RNA revealed that the analogues 2-5 had higher Tm compared with that with oligodeoxynucleoside phosphorothioates. Additionally, the RNA component of the oligo/ RNA duplex is efficiently cleaved by RNase H, the site of endonucleolytic cleavage being dictated by the length of the oligodeoxynucleoside phosphorothioate segment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931938     DOI: 10.1016/0968-0896(96)00160-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

2.  C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2'O-ribose methylation.

Authors:  Eva van Ingen; Daphne A L van den Homberg; M Leontien van der Bent; Hailiang Mei; Nikolina Papac-Milicevic; Veerle Kremer; Reinier A Boon; Paul H A Quax; Johann Wojta; A Yaël Nossent
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 6.150

3.  Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Authors:  Michael J Gait; Sudhir Agrawal
Journal:  Methods Mol Biol       Date:  2022

4.  Inhibition of human telomerase by 2'-O-methyl-RNA.

Authors:  A E Pitts; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 5.  Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2022-09-16       Impact factor: 5.818

Review 6.  Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors.

Authors:  Marina A Dobrovolskaia; Mark Bathe
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.